Przeglądaj Publikacje według tematu "immunotherapy"
Wyświetlanie pozycji 1-1 z 1
-
Attempting to identify bacterial allies in immunotherapy of NSCLC patients
(MDPI, 2022)Introduction: Factors other than PD-L1 (Programmed Death Ligand 1) are being sought as predictors for cancer immuno- or chemoimmunotherapy in ongoing studies and long-term ob- servations. Despite high PD-L1 expression ...